LEVOFLOXACIN (LEVOFLOXACIN) — FDA Approval ANDA203613 (JUBILANT GENERICS)
LEVOFLOXACIN (LEVOFLOXACIN) — FDA Approval ANDA203613 (JUBILANT GENERICS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LEVOFLOXACIN; Active ingredients: LEVOFLOXACIN; Application number: ANDA203613.
| Brand name | LEVOFLOXACIN |
|---|---|
| Active ingredients | LEVOFLOXACIN |
| Application number | ANDA203613 |
| Sponsor | JUBILANT GENERICS |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 20150619 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →